Enarodustat suppresses thymic stromal lymphopoietin expression via hypoxia-inducible factor-mediated c-Jun N-terminal kinases dephosphorylation
PLOS One · 2026
DOI: 10.1371/journal.pone.0341552 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Ryosuke Segawa und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Pharmacotherapy of Life-Style Related Diseases, Graduate School of Pharmaceutical Sciences, Tohoku University, Aoba-ku, Sendai, Japan. Hauptthemen laut MEDLINE: Cytokines, JNK Mitogen-Activated Protein Kinases, Hypoxia-Inducible Factor 1, alpha Subunit. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Thymic stromal lymphopoietin (TSLP) is an epithelial-derived cytokine that induces type 2 immune responses through dendritic cell activation, and its aberrant regulation is implicated in TSLP-associated inflammatory disorders including atopic dermatitis. We previously demonstrated that hypoxia-inducible factor (HIF) suppresses TSLP expression in human keratinocyte cells; however, the underlying mechanism remained unclear. In this study, we aimed to explore the suppressive mechanism of enarodustat, an HIF-prolyl hydroxylase inhibitor. Enarodustat selectively suppressed TSLP expression induced by the fibroblast-stimulating lipopeptide (FSL-1), a toll like receptor 2/6 agonist in HaCaT, a human keratinocyte cell line. Although both the nuclear factor-κB (NF-κB) and activator protein (AP)-1 contributed to FSL-1-induced TSLP induction, enarodustat preferentially attenuated AP-1 signaling by reducing c-Jun N-terminal kinase (JNK) phosphorylation. This JNK dephosphorylation required both HIF1α and HIF2α and was accompanied by increased expression of dual-specificity phosphatases (DUSPs), which target JNK for dephosphorylation. Collectively, our findings identify a previously uncharacterized HIF–DUSP–JNK axis that negatively regulates TSLP expression. This study provides mechanistic insight into how HIF activation shapes epithelial cytokine responses, offering a basis for understanding the pathogenesis of TSLP-associated diseases such as atopic dermatitis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Pharmacotherapy of Life-Style Related Diseases, Graduate School of Pharmaceutical Sciences, Tohoku University, Aoba-ku, Sendai, Japan.
- Department of Pharmaceutical Sciences, Tohoku University Hospital, Sendai, Japan.
- Research Planning and Assessment Office, Tohoku University, Aoba-ku, Sendai, Japan.
ORCID-Profile: Ryosuke Segawa, Noriyasu Hirasawa
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Segawa, R., Yagisawa, M., Miyata, C., & Hirasawa, N. (2026). Enarodustat suppresses thymic stromal lymphopoietin expression via hypoxia-inducible factor-mediated c-Jun N-terminal kinases dephosphorylation. PLOS One. https://doi.org/10.1371/journal.pone.0341552
Vancouver
Segawa R, Yagisawa M, Miyata C, Hirasawa N. Enarodustat suppresses thymic stromal lymphopoietin expression via hypoxia-inducible factor-mediated c-Jun N-terminal kinases dephosphorylation. PLOS One. 2026. doi:10.1371/journal.pone.0341552
BibTeX
@article{Segawa2026,
author = {Segawa, Ryosuke and Yagisawa, Makiko and Miyata, Chihiro and Hirasawa, Noriyasu},
title = {Enarodustat suppresses thymic stromal lymphopoietin expression via hypoxia-inducible factor-mediated c-Jun N-terminal kinases dephosphorylation},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0341552}
}
EUVIMED